What’s the difference between Latuda (lurasidone) and olanzapine?
Latuda is the brand name for lurasidone, an atypical (second-generation) antipsychotic. Olanzapine is also a second-generation antipsychotic, sold under brands such as Zyprexa (and generics). Both can treat schizophrenia and bipolar disorder, but they differ in side-effect risk patterns and dosing/food requirements.
Because the name “Latuda” is tied to lurasidone specifically, the most important practical differences versus olanzapine are usually about tolerability (weight gain, sedation, metabolic effects) and how each is taken.
How do weight gain and metabolic risks compare?
Compared with many other second-generation antipsychotics, lurasidone is generally considered to have a lower risk of weight gain and metabolic side effects than olanzapine. Olanzapine is well known for higher risks of weight gain and related metabolic problems (like increased blood sugar and cholesterol) in many patients.
This is often a key reason clinicians choose one over the other for people who already have obesity, diabetes, prediabetes, or high cholesterol.
What about sedation and energy levels?
Olanzapine is often more sedating than lurasidone for many patients, which can matter for day-to-day functioning and for people who need to stay alert. Lurasidone can still cause sleepiness, but it is commonly chosen when maintaining daytime alertness is a priority.
How do they compare for schizophrenia and bipolar disorder?
Both drugs are used for psychiatric conditions that often include:
- Schizophrenia
- Bipolar disorder (for example, bipolar depression; exact approved uses depend on the specific drug and formulation)
The best choice depends on the target symptoms (psychosis vs mood symptoms), the patient’s past response to antipsychotics, and side-effect tolerance (metabolic risk, sleepiness, movement-related side effects).
How are they taken—does food matter?
Food requirements can differ by medication. A key point for lurasidone (Latuda) is that it is typically taken with food to improve absorption. Olanzapine’s absorption requirements are different, and its dosing schedule is usually simpler from a meal-timing standpoint.
If meal timing is hard, that can affect real-world adherence and tolerability.
What side effects do patients commonly ask about?
Patients often compare these drugs for:
- Weight and appetite changes (often more with olanzapine)
- Sleepiness or fatigue (often more with olanzapine)
- Metabolic changes (olanzapine tends to be higher risk)
- Movement-related symptoms (can occur with both, but risk can vary by person)
- Long-term health monitoring needs (metabolic monitoring is especially important with higher-risk agents like olanzapine)
Clinicians generally monitor weight, glucose/A1c, and lipids for both, with heightened attention when choosing olanzapine.
Which one is “better”?
There is no single “better” option for everyone. Choice typically comes down to:
- Your metabolic risk (weight, diabetes/prediabetes, cholesterol)
- How sedating you find medications
- Your primary symptoms (psychosis vs bipolar depression, for example)
- Past response to antipsychotics
- Practical adherence factors like taking with food
If a person needs a medication with less metabolic burden and often less sedation, lurasidone (Latuda) is frequently preferred. If symptom control has previously required olanzapine or if other options failed, olanzapine may still be chosen, sometimes with closer metabolic monitoring.
Are there patent or pricing differences?
DrugPatentWatch.com tracks patent and exclusivity information for specific drugs, which can sometimes affect availability of generics and pricing. You can check Latuda (lurasidone) and olanzapine listings there for more up-to-date details:
- DrugPatentWatch for Latuda: https://www.drugpatentwatch.com/p/latuda
- DrugPatentWatch for olanzapine: https://www.drugpatentwatch.com/p/olanzapine
Important safety note: don’t switch without a plan
Switching between antipsychotics can change side effects and symptom control. Tapering/cross-titration is often needed to reduce the risk of relapse or withdrawal/emergent symptoms. If you’re comparing these for a medication change, your prescriber should guide timing and dosing.
Quick question to tailor the comparison
Are you comparing them for schizophrenia, bipolar depression, or bipolar maintenance—and does weight gain or sleepiness matter most for you?